Business
Praxis Precision Medicines to Present on Late-Stage Programs across Epilepsy and Movement Disorders at the American Academy of Neurology 2025 Annual Meeting
BOSTON, March 24, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic
About this update from Praxis Precision Medicines, Inc.
[{"type":"text","content":"BOSTON, March 24, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that that it will present data from its four late-stage programs in epilepsy and movement disorders at the American Academy of Neurology (AAN) 2025 Annual Meeting taking place from April 5 to 9, 2025 in San Diego, California. “Praxis’s innovative pipeline continues to rapidly advance, with four late-stage programs poised to transform patient care,” said Steven Petrou, Chief Scientific Officer and Co-Founder of Praxis. “At this year’s AAN, we’re excited to present the latest developments across our diverse portfolio, including key clinical updates from the vormatrigine ENERGY program and newly initiated clinical trials actively enrolling patients across the U.S., Europe, and Latin America. We are especially pleased to host an engaging In-Booth Speaker Showcase featuring renowned experts and collaborators who share our mission of revolutionizing therapies for CNS disorders.” Praxis will have multiple opportunities for visitors to learn more about its portfolio: Exhibiting at booth #2113 where visitors can interact with members of the Praxis team including a dedicated networking event, detailed belowHosting an In-Booth Speaker Showcase covering three of its clinical-stage assets, and featuring an exciting line up of leading epilepsy and movement disorders experts, detailed belowPresenting four unique posters covering two of its clinical-stage assets, detailed below Praxis Booth Connect with members of our team at booth #2113 during exhibit hours or join us for the following: In-Booth Networking Crawl – refreshments served Monday, April 7 | 4:00 PM – 6:00 PM PT | Booth 2113 | Exhibit Hall A-D In Booth Speaker Showcase – Praxis Precision Medicines: Revolutionizing CNS Therapies Sunday 6 April – Wednesday 9 April | 1:30 PM – 3:30 PM PT | Exhibit Hall A-D Praxis Poster Presentations P5-011: Spotlight on Essential Tremor Management and Impact: Results from an Online Survey Capturing HCP and Patient Perspectives of Disease Burden Saturday, April 5 | 11:45 AM – 12:45 PM PT | Exhibit Hall A P5-012: Characteristics of Adult Essent...